Kah Teong Soh
6PUBLICATIONS
82CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Nov 19, 2025
Anti-PD-L2 immunotherapy is efficacious against melanoma in aged hosts through IL-17 and IFNγ signalling.Carlos O Ontiveros, Myrna G Garcia, Clare E Murray
|Nov 14, 2025
The Allogeneic FAP-CAR-IL15 iNKT Therapy MiNK-215 Remodels the Tumor Stroma to Enhance Antitumor Immunity.Eleni Chantzoura, Efrat Altman-Sharoni, Xavier Michelet
|Jul 31, 2024
Botensilimab, an Fc-Enhanced Anti-CTLA-4 Antibody, Is Effective against Tumors Poorly Responsive to Conventional Immunotherapy.Dhan Chand, David A Savitsky, Shanmugarajan Krishnan
|Feb 06, 2024
A phase 1/2 clinical trial of invariant natural killer T cell therapy in moderate-severe acute respiratory distress syndrome.Terese C Hammond, Marco A Purbhoo, Sapana Kadel
|Jun 18, 2022
Development of a 27-color panel for the detection of measurable residual disease in patients diagnosed with acute myeloid leukemia.Kah Teong Soh, Alexis Conway, Xiaojun Liu
|Jan 10, 2022
Evaluation of multiple myeloma measurable residual disease by high sensitivity flow cytometry: An international harmonized approach for data analysis.Kah Teong Soh, Neil Came, Gregory E Otteson
Pageof 1
Frequent Collaborators
3 joint publications
Tyler J Curiel
3 joint publications
Dhan Chand
2 joint publications
Alvaro Sebastian-Yague
2 joint publications
Bishnu Joshi
2 joint publications
Vignesh Venkatraman
2 joint publications
Shannon K Boi
2 joint publications
Shanmugarajan Krishnan
2 joint publications
Marc van Dijk
2 joint publications
Justin Stebbing
2 joint publications
Mark A Exley
